Disclosed are compounds of Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.
申请公布号
US2013072690(A1)
申请公布日期
2013.03.21
申请号
US201213677358
申请日期
2012.11.15
申请人
GLAXOSMITHKLINE LLC;GLAXOSMITHKLINE LLC
发明人
CHEN PINGYUN;COUCH RICKY;DUAN MAOSHENG;GRIMES RICHARD MARTIN;KAZMIERSKI WIESLAW MIECZYSLAW;NORTON BETH ADAMS;TALLANT MATTHEW